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Defining the mechanisms regulating peripheral myelinogenesis in vitro remains a 
daunting task. One of the major complications is related to the inability of Schwann 
cells to produce myelin in vitro. However, a limited number of schwannoma cell lines 
are now being accepted as adequate model systems to study myelin expression since 
they present most of the features that characterize normal myelinating Schwann cells. 
PACAP and VIP peptides have been shown to play part in myelin maturation and 
synthesis in the central nervous system, but no data regarding their potential actions 
have been reported in the peripheral nervous system, particularly in vitro. In this 
study, we investigated the effects of both peptides on the expression of myelin-spe-
cific markers using the well-established rat RT4 schwannoma cell line. In addition, 
we endeavored to partly unravel the underlying molecular mechanisms involved. 
Expression of myelin-specific markers (MAG, MBP and MPZ, respectively) was 
assessed in cells grown either in the presence of normal serum (10% FBS) or serum 
starved and treated with or without 100nM PACAP or VIP. Effects of pharmacological 
blockade of PACAP and VIP receptors as well as of the main signaling pathways on 
the expression of myelin-markers were also determined. Our data shows that serum 
starvation (24h) was sufficient to induce a significant increase in the expression of 
myelin markers. This result was paralleled by a concurrent increase in the endoge-
nous expression of both peptides, as well as of the non-specific PACAP/VIP receptor 
2 (VPAC2), but not of VPAC1 or PAC1. Exogenous PACAP or VIP treatment further 
exacerbated starvation-driven expression of myelin markers, suggesting an active 
role of these peptides in myelin generation. Interestingly, stimulation with either pep-
tides increased phosphorylation levels of Akt at Ser473 residue whereas they did not 
affect Erk1/2 activation. Treatment with the PAC1 receptor antagonist (PACAP6-38) 
had no effects on myelin markers expression while a non-specific VPAC receptor 
antagonist completely abrogated both starvation and/or starvation + peptide-induced 
expression of myelin markers. Similar effects were obtained in cell pretreated with 
the PKA inhibitor (H-89, 10μM), suggesting that peptide-driven induction of myelin 
markers occurs preferentially via the canonical PKA/Akt signaling pathway. In con-
clusion, the results here presented provide the basis for future studies on the role of 
these peptides in physiological myelination and in demyelinating pathologies such as 
Charcot-Mary-Tooth disease.
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